Researchers Plan to Evaluate CORVax12 Vaccine in Phase I Clinical Trial for COVID-19

Providence Cancer Institute at Providence St. Joseph Health is pursuing a first-in-human phase I clinical trial of CORVax12, which is intended to act as a prophylactic vaccine to prevent COVID-19.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news